Indian Immunologicals Limited
Indian Immunologicals Limited (IIL), headquartered in Hyderabad, India, is a prominent player in the biotechnology and pharmaceutical industry. Founded in 1982, IIL has established itself as a leader in the production of vaccines and biopharmaceuticals, focusing on animal health and human health sectors. The company is renowned for its innovative range of products, including vaccines for livestock and poultry, as well as human vaccines. IIL's commitment to quality and research has led to significant milestones, such as the development of India's first indigenous rabies vaccine. With a strong market position, Indian Immunologicals Limited continues to contribute to public health and animal welfare, making it a trusted name in the immunological landscape.
DitchCarbon Score
How does Indian Immunologicals Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Indian Immunologicals Limited's score of 9 is lower than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Indian Immunologicals Limited's reported carbon emissions
Indian Immunologicals Limited, headquartered in India, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting on its emissions. In the context of the biopharmaceutical industry, companies are increasingly recognising the importance of addressing climate change and reducing their carbon footprints. As such, Indian Immunologicals Limited may be exploring strategies to align with industry standards and best practices in sustainability. However, without specific emissions data or targets, it is challenging to assess their current impact or future commitments in relation to carbon emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Indian Immunologicals Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
